<Disease><Name>PROPIONIC ACIDEMIA (PA, PCCA)</Name><Synonym>KETOTIC HYPERGLYCINEMIA; PA; PROPIONIC ACIDEMIA; PCCA</Synonym><OMIM><Number>606054</Number><URL>http://omim.org/entry/606054</URL></OMIM><Orphanet><Number>35</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=35</URL></Orphanet><Protein><Number>Propionyl-CoA carboxylase alpha chain, mitochondrial</Number><URL>https://www.uniprot.org/uniprot/P05165</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>13q32.3</Gene><ICD>E71.1</ICD><Summary>rare (1:50000-200000);autosomal recessive ;prenatal diagnosis in amnion fluid;Since mild C3 elevations may be overlooked and considered non-diagnostic in isolation, we advise considering a diagnosis of propionic acidemia even in the absence of significant elevations 2-methylcitrate or 3-hydroxypropionate in urine organic acid analysis [Cappucio G et al. 2016]</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1877</id><symptom>cardiomegaly</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3676</id><symptom>cardiomyopathy, dilated</symptom><category>CARDIOVASCULAR SYSTEM | CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2452</id><symptom>cerebral edema / brain edema</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2018</id><symptom>decreased body hair</symptom><category>SKIN | SKIN</category></symtomp><symtomp><id>4068</id><symptom>decreased body height</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1714</id><symptom>dehydration</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3390</id><symptom>dermatitis</symptom><category>SKIN</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2217</id><symptom>glaucoma</symptom><category>EYES</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3200</id><symptom>hyperammonemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2094</id><symptom>hypothermia</symptom><category>ENDOCRINE SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3198</id><symptom>ketosis, ketoacidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2425</id><symptom>MRI, brain, gray matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2418</id><symptom>myelination, incomplete, hypomyelination</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2038</id><symptom>neutropenia (decreased neutrophils)</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3776</id><symptom>optic neuropathy</symptom><category>EYES</category></symtomp><symtomp><id>2075</id><symptom>Organic acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3962</id><symptom>osteopenia</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2027</id><symptom>pancytopenia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1993</id><symptom>pyloric stenosis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2007</id><symptom>recurrent or intermittent skin defect</symptom><category>SKIN</category></symtomp><symtomp><id>3498</id><symptom>renal dysfunction, renal defects</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>4097</id><symptom>renal failure, chronic</symptom><category /></symtomp><symtomp><id>1872</id><symptom>respiratory distress</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2143</id><symptom>respiratory insufficiency / respiratory failure</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2006</id><symptom>skin defects</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2263</id><symptom>strokelike episodes</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1869</id><symptom>tachypnea, hyperpnea, dyspnea, hyperventilation</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3199</id><symptom>thrombopenia, thrombocytopenia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1588</id><name>Acetoacetic acid</name><specimen>urine</specimen><value>increased</value><min>2.20</min><max>24.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1589</id><name>Acylcarnitine (C2)</name><specimen>urine</specimen><value>increased</value><min>0.60</min><max>7.50</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1591</id><name>Acetone</name><specimen>urine</specimen><value>increased</value><min>0.80</min><max>17.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>1621</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>44.00</min><max>300.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1622</id><name>Hippuric acid</name><specimen>urine</specimen><value>normal/inc</value><min>19.00</min><max>622.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1639</id><name>L-Carnitine</name><specimen>urine</specimen><value>normal/inc</value><min>0.70</min><max>16.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1646</id><name>Glutamine</name><specimen>urine</specimen><value>normal/inc</value><min>19.10</min><max>77.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1713</id><name>3-Hydroxyvaleric acid</name><specimen>urine</specimen><value>normal/inc</value><min>6.00</min><max>8.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1721</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>93.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1732</id><name>Acetoacetic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1734</id><name>Acetone</name><specimen>urine</specimen><value>increased</value><min>14.00</min><max>110.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1765</id><name>Glutamine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>830.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1766</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>87.00</min><max>1900.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1784</id><name>Propionylglycine</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>2.10</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1786</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>74.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1799</id><name>Hippuric acid</name><specimen>urine</specimen><value>normal/inc</value><min>49.00</min><max>510.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1816</id><name>Propionic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>76.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1869</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>4.40</min><max>17.90</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1942</id><name>Glutamine</name><specimen>plasma</specimen><value>normal decreased</value><min>457.00</min><max>857.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1943</id><name>Glutamine</name><specimen>plasma</specimen><value>normal decreased</value><min>205.00</min><max>756.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1944</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>122.00</min><max>550.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1945</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>166.00</min><max>330.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1946</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>130.00</min><max>400.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>2053</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>23.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2055</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>24.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2057</id><name>Propionylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2059</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2148</id><name>Quick</name><specimen>blood</specimen><value>decreased</value><min>70.00</min><max>130.00</max><unit>%</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>701</id><name>3-Hydroxybutyrate + Acetoacetate</name><specimen>plasma</specimen><value>decreased</value><min>0.00</min><max>0.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>5</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>30.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>506</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>34.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>530</id><name>3-Hydroxypropionic acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>710</id><name>3-Hydroxypropionic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>709</id><name>3-Hydroxypropionic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>9.50</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>7</id><name>3-Hydroxyvaleric acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1324</id><name>3-Hydroxyvaleric acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>72</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>42.00</min><max>115.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>560</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>563</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1168</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>77.00</min><max>133.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1284</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>blood</specimen><value>increased</value><min>14.00</min><max>62.54</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1285</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>serum</specimen><value>increased</value><min>23.80</min><max>106.32</max><unit>&#181;mol/ml</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1356</id><name>Acetoacetic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>24</id><name>Acetoacetic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>370</id><name>Acetoacetic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>32.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>371</id><name>Acetoacetic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>86.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1355</id><name>Acetoacetic acid</name><specimen>urine</specimen><value>increased</value><min>    </min><max>1.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1212</id><name>Acylcarnitine (C2)</name><specimen>blood</specimen><value>increased</value><min>12.40</min><max>50.70</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1216</id><name>Acylcarnitine (C2)</name><specimen>serum</specimen><value>increased</value><min>21.10</min><max>86.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1992</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>19.00</min><max>71.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>9</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>25.00</min><max>80.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>1092</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>11.00</min><max>68.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>37</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>45.00</min><max>97.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>278</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>36.00</min><max>110.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>277</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>47.00</min><max>91.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>276</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>41.00</min><max>79.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>275</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>28.00</min><max>56.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>274</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>24.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>273</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>27.00</min><max>59.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>279</id><name>Ammonia</name><specimen>blood</specimen><value>normal/inc</value><min>27.00</min><max>57.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>270</id><name>L-Carnitine</name><specimen>urine</specimen><value>normal/inc</value><min>8.00</min><max>21.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>272</id><name>L-Carnitine</name><specimen>urine</specimen><value>normal/inc</value><min>0.60</min><max>15.40</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1214</id><name>L-Carnitine</name><specimen>blood</specimen><value>normal/inc</value><min>6.83</min><max>43.45</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1215</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>11.61</min><max>73.87</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>59</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>23.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>268</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>35.00</min><max>55.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1090</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>20.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1163</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>15.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1213</id><name>L-Carnitine</name><specimen>blood</specimen><value>decreased</value><min>10.00</min><max>44.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1141</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>13.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1142</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>11.50</min><max>18.00</max><unit>&#181;mol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>1143</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>18.00</min><max>30.00</max><unit>&#181;mol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>267</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>40.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1089</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>9.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>15</id><name>Glutamine</name><specimen>urine</specimen><value>decreased</value><min>52.00</min><max>205.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>858</id><name>Glutamine</name><specimen>urine</specimen><value>decreased</value><min>45.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>14</id><name>Glutamine</name><specimen>plasma</specimen><value>normal decreased</value><min>178.00</min><max>886.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>706</id><name>Glutamine</name><specimen>plasma</specimen><value>normal decreased</value><min>333.00</min><max>809.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>36</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>210.00</min><max>743.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>830</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>110.00</min><max>356.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>862</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>283.00</min><max>1097.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1414</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>180.00</min><max>1633.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>1-7d</comment></metabolite><metabolite><id>1909</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>64.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1910</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>43.00</min><max>173.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>35</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>230.00</min><max>500.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>474</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.90</min><max>10.00</max><unit>&#956;mol/l</unit><age>3m-10years</age><method /><comment /></metabolite><metabolite><id>977</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>100.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>738</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.02</min><max>0.04</max><unit>ratio</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1272</id><name>Glycine</name><specimen>blood</specimen><value>increased</value><min>85.10</min><max>536.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1273</id><name>Glycine</name><specimen>serum</specimen><value>increased</value><min>144.67</min><max>911.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1478</id><name>Hippuric acid</name><specimen>urine</specimen><value>normal/inc</value><min>190.00</min><max>330.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1371</id><name>Hippuric acid</name><specimen>urine</specimen><value>normal/inc</value><min>2.00</min><max>122.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1372</id><name>Hippuric acid</name><specimen>urine</specimen><value>normal/inc</value><min>119.00</min><max>1390.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>386</id><name>Hippuric acid</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>387</id><name>Hippuric acid</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>5.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>487</id><name>Human growth hormone (hGH)</name><specimen>plasma</specimen><value>decreased</value><min>10.00</min><max>40.00</max><unit>&#181;g/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>488</id><name>Human growth hormone (hGH)</name><specimen>plasma</specimen><value>decreased</value><min>12.00</min><max>15.00</max><unit>ng/ml</unit><age>child</age><method /><comment /></metabolite><metabolite><id>475</id><name>Ketone bodies (urine)</name><specimen>urine</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>2025</id><name>L-Carnitine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>1906</id><name>Glutamine</name><specimen>urine</specimen><value>normal/inc</value><min>63.00</min><max>229.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1907</id><name>Glutamine</name><specimen>urine</specimen><value>normal/inc</value><min>20.00</min><max>112.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1908</id><name>Glutamine</name><specimen>urine</specimen><value>normal/inc</value><min>20.00</min><max>76.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1977</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>10.20</min><max>32.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>394</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>plasma</specimen><value>increased</value><min>13.00</min><max>161.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>559</id><name>L-Pyroglutamic acid (5-Oxoproline)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>4</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>596</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>597</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>18.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>599</id><name>Methylcitric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>61</id><name>pCO2</name><specimen>blood</specimen><value>normal/dec</value><min>38.00</min><max>42.00</max><unit>mm Hg</unit><age>child</age><method /><comment /></metabolite><metabolite><id>793</id><name>pH</name><specimen>urine</specimen><value>normal/dec</value><min>6.00</min><max>7.00</max><unit>no unit</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>60</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.35</min><max>7.45</max><unit>no unit</unit><age>child</age><method /><comment /></metabolite><metabolite><id>302</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.20</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>303</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.30</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>301</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.30</min><max>7.50</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>300</id><name>pH</name><specimen>blood</specimen><value>decreased</value><min>7.10</min><max>7.40</max><unit>no unit</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1399</id><name>Propionic acid</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>45</id><name>Propionic acid</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>781</id><name>Propionyl CoA carboxylase</name><specimen>fibroblasts</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1217</id><name>Propionylcarnitine (C3)</name><specimen>blood</specimen><value>increased</value><min>1.03</min><max>5.99</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1218</id><name>Propionylcarnitine (C3)</name><specimen>serum</specimen><value>increased</value><min>1.75</min><max>10.18</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>6</id><name>Propionylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1339</id><name>Propionylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>607</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>608</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>43</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>605</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>7.60</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>606</id><name>Tiglylglycine</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>6.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7347</id><title>Liver Transplantation for Propionic Acidemia: A Multicenter-linked Database Analysis</title><author>Alexopoulos SP,</author><journal>J Pediatr Gastroenterol Nutr</journal><year>2020</year><book /><volume>70</volume><number>2</number><pages>178-182</pages><co_aut>et al.</co_aut></literature><literature><id>7446</id><title>Combinations of exonic deletions and rare mutations lead to misdiagnosis of propionic acidemia</title><author>Wang H,</author><journal>Clin Chim Acta</journal><year>2020</year><book /><volume>502</volume><number>0</number><pages>153-158</pages><co_aut>et al.</co_aut></literature><literature><id>7447</id><title>Cardiac phenotype in propionic acidemia - Results of an observational monocentric study</title><author>Kovacevic A,</author><journal>Mol Genet Metab</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7448</id><title>[Propionic acidemia: clinical diagnosis vs newborn screening]</title><author>Felez Moliner I,</author><journal>Arch Argent Pediatr</journal><year>2020</year><book /><volume>118</volume><number>1</number><pages>e53-56</pages><co_aut>et al.</co_aut></literature><literature><id>8059</id><title>Plasma Methylcitric Acid and Its Correlations With Other Disease Biomarkers: The Impact in The Follow Up of Patients With Propi</title><author>Maines E,</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>8069</id><title>Impaired lipolysis in propionic acidemia: A new metabolic myopathy?</title><author>Stoorgard H,</author><journal>JIMD Rep</journal><year>2020</year><book /><volume>53</volume><number>1</number><pages>16-21</pages><co_aut>et al.</co_aut></literature><literature><id>8071</id><title>Case reports: three novel variants in PCCA and PCCB genes in Chinese patients with propionic acidemia</title><author>Yang Q,</author><journal>BMC Med Genet</journal><year>2020</year><book /><volume>21</volume><number>1</number><pages>72</pages><co_aut>et al.</co_aut></literature><literature><id>6778</id><title>Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications</title><author>Haijes HA,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>5</number><pages>730-744</pages><co_aut>et al.</co_aut></literature><literature><id>6779</id><title>Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies</title><author>Haijes HA,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>5</number><pages>745-761</pages><co_aut>et al.</co_aut></literature><literature><id>6827</id><title>Spectrum of mutations underlying Propionic acidemia and further insight into a genotype-phenotype correlation for the common mutation in Saudi Arabia</title><author>Al-Hamed MH,</author><journal>Mol Genet Metab Rep</journal><year>2019</year><book /><volume>18</volume><number>0</number><pages>22-29</pages><co_aut>et al.</co_aut></literature><literature><id>6999</id><title>Assessment of methylcitrate and methylcitrate to citrate ratio in dried blood spots as biomarkers for inborn errors of propiona</title><author>Al-Dirbashi OY,</author><journal>Sci Rep</journal><year>2019</year><book /><volume>9</volume><number>1</number><pages>12366</pages><co_aut>et al.</co_aut></literature><literature><id>7000</id><title>Multi-omics studies in cellular models of methylmalonic acidemia and propionic acidemia reveal dysregulation of serine metaboli</title><author>Anzmann AF,</author><journal>Biochim Biophys Acta Mol Basis Dis. 2019 Aug 23:165538.</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7001</id><title>Chronic kidney disease in propionic acidemia</title><author>Shchelochkov OA,</author><journal>Genet Med</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7002</id><title>Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized co</title><author>Nashabat M,</author><journal>BMC Pediatr</journal><year>2019</year><book /><volume>19</volume><number>1</number><pages>195</pages><co_aut>et al.</co_aut></literature><literature><id>7269</id><title>Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: </title><author>Haijes HA,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6388</id><title>Quantification of methylcitrate in dried urine spots by liquid chromatography tandem mass spectrometry for the diagnosis of pro</title><author>Al Dhahouri N,</author><journal>Clin Chim Acta</journal><year>2018</year><book /><volume>487</volume><number>0</number><pages>41-45</pages><co_aut>et al.</co_aut></literature><literature><id>6389</id><title>Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias</title><author>Molema F,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>41</volume><number>6</number><pages>1179-1187</pages><co_aut>et al.</co_aut></literature><literature><id>6392</id><title>Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes</title><author>Critelli K,</author><journal>Liver Transpl</journal><year>2018</year><book /><volume>24</volume><number>9</number><pages>1260-1270</pages><co_aut>et al.</co_aut></literature><literature><id>6486</id><title>Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories</title><author>Haeberle J,</author><journal>Orphanet J Rare Dis</journal><year>2018</year><book /><volume>13</volume><number>1</number><pages>219</pages><co_aut>et al.</co_aut></literature><literature><id>6825</id><title>Epilepsy in Propionic Acidemia: Case Series of 14 Saudi Patients</title><author>AlGhamdi A,</author><journal>J Child Neurol</journal><year>2018</year><book /><volume>33</volume><number>11</number><pages>713-717</pages><co_aut>et al.</co_aut></literature><literature><id>5406</id><title>Autism spectrum disorders in propionic acidemia patients</title><author>de la Batie CD,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5443</id><title>Dietary practices in propionic acidemia: A European survey</title><author>Daly A,</author><journal>Mol Genet Metab Rep</journal><year>2017</year><book /><volume>13</volume><number>0</number><pages>83-89</pages><co_aut>et al.</co_aut></literature><literature><id>3044</id><title>Propionic Acidemia</title><author>Shchelochkov OA,</author><journal>GeneReviews&#174; [Internet]</journal><year>2016</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Carrillo N, Venditti C</co_aut></literature><literature><id>3360</id><title>Optic neuropathy in methylmalonic acidemia and propionic acidemia</title><author>Martinez Alvarez,</author><journal>Br J Ophthalmol</journal><year>2016</year><book /><volume>100</volume><number>1</number><pages>98-104</pages><co_aut>et al.</co_aut></literature><literature><id>4402</id><title>Methylmalonic and propionic acidemias: clinical management update</title><author>Fraser JL,</author><journal>Curr Opin Pediatr</journal><year>2016</year><book /><volume>28</volume><number>6</number><pages>682-693</pages><co_aut>Venditti CP</co_aut></literature><literature><id>5683</id><title>Autism in patients with propionic acidemia</title><author>Witters P,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>119</volume><number>4</number><pages>317-321</pages><co_aut>et al.</co_aut></literature><literature><id>3358</id><title>Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias</title><author>Malvagia S,</author><journal>Clin Chim Acta</journal><year>2015</year><book /><volume>450</volume><number>0</number><pages>342-348</pages><co_aut>et al.</co_aut></literature><literature><id>3359</id><title>Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up</title><author>Arrizza C,</author><journal>Transpl Int</journal><year>2015</year><book /><volume>28</volume><number>12</number><pages>1447-1450</pages><co_aut>et al.</co_aut></literature><literature><id>3361</id><title>Early and late complications after liver transplantation for propionic acidemia in children: a two centers study</title><author>Charbit-Henrion F,</author><journal>Am J Transplant</journal><year>2015</year><book /><volume>15</volume><number>3</number><pages>786-791</pages><co_aut>et al.</co_aut></literature><literature><id>3362</id><title>Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia</title><author>Baumgartner MR,</author><journal>Orphanet J Rare Dis</journal><year>2014</year><book /><volume>9</volume><number>0</number><pages>130</pages><co_aut>et al.</co_aut></literature><literature><id>3363</id><title>Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secon</title><author>Baruteau J,</author><journal>Mitochondrion</journal><year>2014</year><book /><volume>17</volume><number>0</number><pages>150-156</pages><co_aut>et al.</co_aut></literature><literature><id>3364</id><title>Propionic acidemia in a previously healthy adolescent with acute onset of dilated cardiomyopathy</title><author>Laemmle A,</author><journal>Eur J Pediatr</journal><year>2014</year><book /><volume>173</volume><number>7</number><pages>971-974</pages><co_aut>et al.</co_aut></literature><literature><id>3365</id><title>Emerging trends in management of propionic acidemia</title><author>Rafique M</author><journal>Arq Bras Endocrinol Metabol</journal><year>2014</year><book /><volume>58</volume><number>3</number><pages>237-242</pages><co_aut /></literature><literature><id>3366</id><title>Propionic acidemia: diagnosis and neuroimaging findings of this neurometabolic disorder</title><author>Karimzadeh P,</author><journal>Iran J Child Neurol</journal><year>2014</year><book /><volume>8</volume><number>1</number><pages>58-61</pages><co_aut>et al.</co_aut></literature><literature><id>3043</id><title>Survey of health status and complications among propionic acidemia patients</title><author>Pena L,</author><journal>Am J Med GEnet</journal><year>2012</year><book /><volume>158</volume><number>7</number><pages>1641-46</pages><co_aut>Burton BK</co_aut></literature><literature><id>3045</id><title>Juvenile glaucoma in propionic acidemia</title><author>Rosentreter A,</author><journal>Ophthalmologe</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6826</id><title>Epilepsy in patients with propionic acidemia</title><author>Haberlandt E,</author><journal>Neuropediatrics</journal><year>2009</year><book /><volume>40</volume><number>3</number><pages>120-125</pages><co_aut>et al.</co_aut></literature><literature><id>2372</id><title>Breastfeeding experience in inborn errors of metabolism other than phenylketonuria</title><author>Huner G</author><journal>J Inherit Metab Dis</journal><year>2005</year><book /><volume>28</volume><number>4</number><pages>457-465</pages><co_aut>et al.</co_aut></literature><literature><id>2380</id><title>Methylmalonic and propionic acidaemias: management and outcome</title><author>Ogier de Baulny HO</author><journal>J Inherit Metab Dis</journal><year>2005</year><book /><volume>28</volume><number>3</number><pages>415-423</pages><co_aut>et al.</co_aut></literature><literature><id>2111</id><title>Propionic acidemia: unusual course with late onset and fatal outcome</title><author>Lucke T</author><journal>Metabolism</journal><year>2004</year><book /><volume>53</volume><number>6</number><pages>809-810</pages><co_aut>et al.</co_aut></literature><literature><id>2112</id><title>The importance of gut motility in the metabolic control of propionic acidemia</title><author>Prasad C</author><journal>J Pediatr</journal><year>2004</year><book /><volume>144</volume><number>4</number><pages>562-535</pages><co_aut>et al.</co_aut></literature><literature><id>2110</id><title>Liver transplantation for propionic acidaemia in a 14-month-old male</title><author>Kim TW</author><journal>Paediatr Anaesth</journal><year>2003</year><book /><volume>13</volume><number>6</number><pages>554-556</pages><co_aut>Hall SR</co_aut></literature><literature><id>1358</id><title>Unexpectedly high prevalence of the mild form of propionic acidemia in Japan: presence of a common mutation and possible clinic</title><author>Yorifuji T</author><journal>Hum Genet</journal><year>2002</year><book /><volume>111</volume><number>2</number><pages>161-165</pages><co_aut>et al.</co_aut></literature><literature><id>2374</id><title>The management of organic acidaemias: the role of transplantation</title><author>Leonard JV</author><journal>J Inherit Metab Dis</journal><year>2001</year><book /><volume>24</volume><number>2</number><pages>309-311</pages><co_aut>Walter JH, McKiernan PJ</co_aut></literature><literature><id>1139</id><title>The use of intravenous sodium benzoate and sodium phenylacetate in propionic acidemia with hyperammonemia</title><author>Praphanphoj V</author><journal>J Inher Met Dis Suppl 1</journal><year>2000</year><book /><volume>23</volume><number>0</number><pages>91</pages><co_aut>et al.</co_aut></literature><literature><id>1003</id><title>5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle</title><author>Mayatepek E</author><journal>Eur J Pediatr</journal><year>1999</year><book /><volume>158</volume><number>0</number><pages>221-225</pages><co_aut /></literature><literature><id>1101</id><title>Identification of novel mutations in the PCCB gene in European propionic acidemia patients. Mutation in brief no. 253</title><author>Muro S</author><journal>Hum Mutat</journal><year>1999</year><book /><volume>14</volume><number>0</number><pages>89-90</pages><co_aut>et al.</co_aut></literature><literature><id>1010</id><title>Stable isotope studies in propionic and methylmalonic acidaemia</title><author>Leonard JV</author><journal>Eur J Pediatr Suppl. 1</journal><year>1997</year><book /><volume>156</volume><number>0</number><pages>S67-69</pages><co_aut>et al.</co_aut></literature><literature><id>201</id><title>Clinical outcome and long-term management of 17 patients with propionic acidemia</title><author>van der Meer SB</author><journal>Eur J Pediatr</journal><year>1996</year><book /><volume>155</volume><number>0</number><pages>205-210</pages><co_aut>et al.</co_aut></literature><literature><id>512</id><title>A study of the response to protein-modified diets for propionic acidemia in twelve patients</title><author>Thomas E</author><journal>Brain Dev (Suppl)</journal><year>1996</year><book /><volume>16</volume><number>0</number><pages>58-63</pages><co_aut /></literature><literature><id>514</id><title>Primary treatment of propionic acidemia complicated by acute thiamine deficiency</title><author>Matern D</author><journal>J Pediatr</journal><year>1996</year><book /><volume>129</volume><number>5</number><pages>758-760</pages><co_aut>et al.</co_aut></literature><literature><id>583</id><title>Plasma total odd-chain fatty acids in the monitoring of disorders of propionate, methylmalonate and biotin metabolism</title><author>Coker M</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>743-751</pages><co_aut>et al.</co_aut></literature><literature><id>55</id><title>Liver transplantation in two cases of propionic acidemia</title><author>Schlenzig JS</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>448-461</pages><co_aut>Poggi-Travert F, Laurent J, Rabier D, Jan D, Wendel U, Sewell AC, Revillon Y, Kamoun P, Saudubray JM</co_aut></literature><literature><id>56</id><title>The management and outcome of propionic and methylmalonic acidemia</title><author>Leonard JV</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>430-434</pages><co_aut /></literature><literature><id>91</id><title>Inherited disorders of cobalamin transport and metabolism</title><author>Fenton WA</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>3129-3249</pages><co_aut>Rosenberg LE</co_aut></literature><literature><id>543</id><title>On the differences between urinary metabolite excretion and odd-numbered fatty acid production in propionic and methylmalonic ac</title><author>Wendel U</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>5</number><pages>584-591</pages><co_aut>et al.</co_aut></literature><literature><id>230</id><title>Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients</title><author>Lehnert W</author><journal>Eur J Pediatr Suppl</journal><year>1994</year><book /><volume>153</volume><number>0</number><pages>S68-S80</pages><co_aut>Sperl W, Suormala T, Baumgartner ER</co_aut></literature><literature><id>418</id><title>Cutaneous manifestations of methylmalonic and propionic acidaemia: a description based on 38 cases</title><author>Bodemer C</author><journal>Br J Dermatol</journal><year>1994</year><book /><volume>131</volume><number>0</number><pages>93-98</pages><co_aut>et al.</co_aut></literature><literature><id>513</id><title>Anabolic effect of human growth hormone: management of inherited disorders of catabolic pathways</title><author>Marsden D</author><journal>Biochem Med Metab Biol</journal><year>1994</year><book /><volume>52</volume><number>2</number><pages>145-154</pages><co_aut>et al.</co_aut></literature><literature><id>521</id><title>Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria</title><author>de Raeve L</author><journal>J Pediatr</journal><year>1994</year><book /><volume>124</volume><number>3</number><pages>416-420</pages><co_aut>et al.</co_aut></literature><literature><id>1011</id><title>The use of metronidazole in management of methylmalonic and propionic acidaemias</title><author>Thompson GN</author><journal>Eur J Pediatr</journal><year>1990</year><book /><volume>149</volume><number>11</number><pages>792-796</pages><co_aut>et al.</co_aut></literature><literature><id>840</id><title>L-carnitine therapy in propionic acidemia</title><author>Roe CR</author><journal>Lancet</journal><year>1982</year><book /><volume>0</volume><number>0</number><pages>1411-1412</pages><co_aut>Bohan TP</co_aut></literature><literature><id>3197</id><title>Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases</title><author>Blau N</author><journal>Springer</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature></Literatures></Disease>